Credit: Getty Images. Camcevi is a ready-to-use 6-month subcutaneous depot formulation of leuprolide mesylate, a gonadotropin-releasing hormone agonist. Camcevi ® (leuprolide mesylate) 42mg injection ...

Subcutaneous (subQ or SQ) injections are shots given in the fatty tissue layer (subcutaneous fat) under your skin. Your skin has many layers, and the subcutaneous layer is beneath the epidermis and ...

Accord BioPharma has tapped Eversana to support Camcevi, a treatment for advanced prostate cancer, in the U.S. The drug was approved by the Food and Drug Administration in May 2021 and is billed as ...

Building a crowd-sourced challenge using clinical trial data.